A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease
出版年份 2016 全文链接
标题
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease
作者
关键词
-
出版物
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 111, Issue 11, Pages 1599-1607
出版商
Springer Nature
发表日期
2016-08-02
DOI
10.1038/ajg.2016.298
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
- (2015) Reena Khanna et al. LANCET
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
- (2014) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis/Systematic review Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis
- (2013) Paweł Kawalec et al. Archives of Medical Science
- O037 Differential roles for IL-23 and IL-17 in inflammatory bowel disease
- (2012) J.E. Towne et al. CYTOKINE
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review article: loss of response to anti-TNF treatments in Crohn’s disease
- (2011) S. Ben-Horin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease
- (2011) S. W. Kim et al. GUT
- Practical application of anti-TNF therapy for luminal Crohnʼs disease
- (2011) Michael A. Kamm et al. INFLAMMATORY BOWEL DISEASES
- Control of TH17 cells occurs in the small intestine
- (2011) Enric Esplugues et al. NATURE
- LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study
- (2010) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Management of Crohn's Disease in Adults
- (2009) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- IL-23/IL-17 immunity as a hallmark of Crohnʼs disease
- (2008) Veera Hölttä et al. INFLAMMATORY BOWEL DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More